HDAC9 and acute myeloid leukemia: HDAC inhibitors induce acetylation and displacement of c-Myc from the promoter and Sp1 is freed to promote transcription of TRAIL and induction of apoptosis in primary blasts derived from AML patients (Fig. 5a).269